Aripiprazole
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Aripiprazole and local guidelines before prescribing.
Mechanism
Partial agonist at dopamine D2 and serotonin 5-HT1A, antagonist at 5-HT2A.
Uses
Schizophrenia, mania in bipolar disorder, adjunct in depression.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Akathisia, insomnia, nausea, restlessness; low prolactin and metabolic effect compared with others; impulse-control problems.
Interactions
CYP2D6 and CYP3A4 inhibitors increase levels; inducers lower levels.
Contraindications and cautions
Caution in cardiovascular disease, epilepsy, dementia
Monitoring
Weight, glucose, lipids, akathisia
Pregnancy and breastfeeding
Use if benefit outweighs risk
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive; activated charcoal early
Special advice
Monitor weight, glucose and lipids; ask about impulsive behaviours such as gambling.
More from the textbook: uses, cautions and other points
- Stop the drug if possible - recovery can take months. If an antipsychotic is essential, switch to one with lower risk (quetiapine, clozapine, aripiprazole).
Neurology: Movement Disorders - Drugs for disabling tics: aripiprazole , clonidine or guanfacine (also helps ADHD), risperidone.
Neurology: Movement Disorders - Tourette syndrome - multiple motor tics and at least one vocal tic for over a year, starting before 18; associated with ADHD, OCD and anxiety. Education, behavioural therapy (habit reversal, CBIT); medication (aripiprazole, clonidine) if severe.
Paediatrics: Neurology, bones and joints in children - Severe or refractory - specialist services; antipsychotic augmentation (e.g. aripiprazole, risperidone); deep brain stimulation (research).
Psychiatry: Anxiety, stress and somatic disorders - Behaviour that challenges - look for pain, illness, sensory overload or anxiety first; positive behaviour support; antipsychotics (risperidone or aripiprazole) only short term for severe aggression, with specialist monitoring.
Psychiatry: Safeguarding - Risperidone / aripiprazole | Short-term for severe aggression in autism or learning disability (specialist); weight gain, metabolic monitoring, prolactin (risperidone); tics (aripiprazole).
Psychiatry: Safeguarding
Where it is discussed in the book
- Neurology: Movement Disorders (3 mentions)
- Paediatrics: Neurology, bones and joints in children (1 mention)
- Psychiatry: Anxiety, stress and somatic disorders (1 mention)
- Psychiatry: Safeguarding (2 mentions)
- Psychiatry: Mood disorders (3 mentions)
- Psychiatry: Alcohol, drugs and addiction (1 mention)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)
- Psychiatry: Psychosis and schizophrenia (10 mentions)
- Integrated paediatrics chapter (1 mention)